Cargando…

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer

Non-small-cell lung cancer (NSCLC) is one of the most common types of cancer worldwide. Accumulating evidence has suggested that aberrant expression of microRNAs (miRNAs) is involved in the carcinogenesis and progression of NSCLC. The current study is aimed at investigating the clinical significance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fayong, Li, Tianshui, Hu, Ping, Dai, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946467/ https://www.ncbi.nlm.nih.gov/pubmed/33763157 http://dx.doi.org/10.1155/2021/8819934

Ejemplares similares

Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma
por: Li, Xuesen, et al.
Publicado: (2020)

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
por: Li, Yunxia, et al.
Publicado: (2018)

Serum exosomal miR‐378 upregulation is associated with poor prognosis in non–small‐cell lung cancer patients
por: Zhang, Yan, et al.
Publicado: (2020)

Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma
por: Bai, Ming, et al.
Publicado: (2017)

miR-629 targets FOXO3 to promote cell apoptosis in gastric cancer
por: Li, Ming, et al.
Publicado: (2020)

MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
por: Yan, Haijiao, et al.
Publicado: (2017)

MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP
por: Zhao, Mei, et al.
Publicado: (2019)

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
por: Zhang, Xianwei, et al.
Publicado: (2018)

Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues
por: Xu, Li-Min, et al.
Publicado: (2015)

MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13
por: Liu, Yangzhou, et al.
Publicado: (2021)

MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4
por: Lu, Jinlai, et al.
Publicado: (2018)

Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion
por: Xia, Jinbing, et al.
Publicado: (2020)

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
por: Wang, Jin, et al.
Publicado: (2017)

Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis
por: Bai, Xiuhui, et al.
Publicado: (2021)

Downregulation of serum exosomal miR‐320d predicts poor prognosis in hepatocellular carcinoma
por: Li, Wenxiao, et al.
Publicado: (2020)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer
por: Wang, Jiying, et al.
Publicado: (2021)

High circulating miR‐18a, miR‐20a, and miR‐92a expression correlates with poor prognosis in patients with non‐small cell lung cancer
por: Xu, Xiaoxiao, et al.
Publicado: (2017)

Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
por: Tang, Ruixue, et al.
Publicado: (2015)

CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
por: Chikuda, Junichiro, et al.
Publicado: (2020)

Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer
por: Sui, Minghua, et al.
Publicado: (2017)

Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287()
por: Wang, Yan, et al.
Publicado: (2019)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Serum miR‐195‐5p is upregulated in gestational diabetes mellitus
por: Wang, Jianping, et al.
Publicado: (2020)

LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis
por: Gong, Jun, et al.
Publicado: (2021)

Diagnostic value of serum miR197 and miR145 in non-small cell lung cancer
por: Sui, Ankui, et al.
Publicado: (2019)

Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma
por: Chen, Xiao-Yu, et al.
Publicado: (2018)

Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion
por: Si, Xiaohui, et al.
Publicado: (2016)

Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells
por: Dong, Anbing, et al.
Publicado: (2020)

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met
por: Cao, Xiaonian, et al.
Publicado: (2017)

Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
por: Ding, Hao, et al.
Publicado: (2020)

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]
Publicado: (2023)

Identification of serum miR-378 and miR-575 as diagnostic indicators and predicting surgical prognosis in human epilepsy
por: Li, Xiuxiu, et al.
Publicado: (2022)

Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
por: Su, Ying Ying, et al.
Publicado: (2019)

miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma
por: Liang, Yicheng, et al.
Publicado: (2017)

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Zhu, WangYu, et al.
Publicado: (2016)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

miR-21, miR-221, and miR-222 upregulation in lung cancer promotes metastasis by reducing oxidative stress and apoptosis
por: Tepebaşı, Muhammet Yusuf, et al.
Publicado: (2023)

miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer
por: Gao, Su-Jun, et al.
Publicado: (2018)

miR-20b overexpression is predictive of poor prognosis in gastric cancer
por: Xue, Tong-min, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h8bonirmbpfvq28hk6egkmhp33